Methods and compositions for the prophylactic and therapeutic treatment of ophthalmic disorders associated with the posterior segment of the eye using topical ophthalmic compositions comprising therapeutic agents. The invention specifically provides for methods and compositions for the prophylactic and therapeutic treatment of retinal disorders associated with neovascularization using topical ophthalmic compositions comprising hydroxamic acid matrix metalloproteinase inhibitors such as batimastat.